Symbols / /PSNL
/PSNL Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
- Personalis Stock Pre-Market (-5.3%): FY26 Guidance Overshadows Q4 EPS Beat - Trefis Fri, 06 Mar 2026 11
- Morgan Stanley Has Lowered Expectations for Personalis (NASDAQ:PSNL) Stock Price - MarketBeat hu, 05 Mar 2026 19
- Insider Purchase: 10% owner at $PSNL Buys 31,430 Shares - Quiver Quantitative Fri, 13 Feb 2026 08
- PSNL: Morgan Stanley Maintains Equal-Weight, Lowers Price Target - GuruFocus hu, 05 Mar 2026 20
- Precision oncology genomics firm Personalis heads to TD Cowen conference - Stock Titan ue, 17 Feb 2026 08
- Personalis, Inc. (PSNL): A Bull Case Theory - Yahoo Finance Mon, 02 Feb 2026 08
- Personalis: A Growth Inflection Is Imminent, Hold - Seeking Alpha hu, 27 Nov 2025 08
- $PSNL stock is up 13% today. Here's what we see in our data. - Quiver Quantitative hu, 22 Jan 2026 08
- PSNL Stock Sees Price Target Increase by Needham | PSNL Stock Ne - GuruFocus Fri, 27 Feb 2026 08
- Personalis (PSNL) Faces Persistent Losses and High Valuation as Revenue Growth Outpaces Market - Yahoo Finance hu, 06 Nov 2025 08
- Medicare to cover blood test that flags returning lung cancer earlier - Stock Titan ue, 10 Feb 2026 08
- $PSNL stock is up 9% today. Here's what we see in our data. - Quiver Quantitative ue, 10 Feb 2026 08
- Would You Still Hold Personalis Stock If It Fell Another 30%? - Trefis Fri, 26 Dec 2025 08
- Medicare now covers a breast cancer blood test to watch for recurrence - Stock Titan hu, 08 Jan 2026 08
- $PSNL stock is up 8% today. Here's what we see in our data. - Quiver Quantitative hu, 16 Oct 2025 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.00 | 0.21 |
| NormalizedEBITDA | -71.00M | -70.30M | -83.17M | -104.64M |
| TotalUnusualItems | 0.00 | -13.64M | 0.00 | 0.00 |
| TotalUnusualItemsExcludingGoodwill | 0.00 | -13.64M | 0.00 | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -81.27M | -81.28M | -108.30M | -113.31M |
| ReconciledDepreciation | 10.05M | 10.94M | 11.30M | 8.43M |
| ReconciledCostOfRevenue | 53.87M | 57.79M | 55.27M | 51.70M |
| EBITDA | -71.00M | -70.30M | -96.81M | -104.64M |
| EBIT | -81.04M | -81.24M | -108.10M | -113.07M |
| NetInterestIncome | 6.95M | 5.49M | 5.79M | 2.19M |
| InterestExpense | 205.00K | 24.00K | 110.00K | 201.00K |
| InterestIncome | 7.16M | 5.51M | 5.90M | 2.40M |
| NormalizedIncome | -81.27M | -81.28M | -94.65M | -113.31M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -81.27M | -81.28M | -108.30M | -113.31M |
| TotalExpenses | 157.71M | 152.88M | 169.78M | 180.58M |
| TotalOperatingIncomeAsReported | -88.06M | -68.27M | -109.94M | -115.53M |
| DilutedAverageShares | 59.25M | 48.18M | 45.70M | 43.89M |
| BasicAverageShares | 59.25M | 48.18M | 45.70M | 43.89M |
| DilutedEPS | -1.37 | -2.25 | -2.48 | -1.49 |
| BasicEPS | -1.37 | -2.25 | -2.48 | -1.49 |
| DilutedNIAvailtoComStockholders | -81.27M | -81.28M | -108.30M | -113.31M |
| NetIncomeCommonStockholders | -81.27M | -81.28M | -108.30M | -113.31M |
| NetIncome | -81.27M | -81.28M | -108.30M | -113.31M |
| NetIncomeIncludingNoncontrollingInterests | -81.27M | -81.28M | -108.30M | -113.31M |
| NetIncomeContinuousOperations | -81.27M | -81.28M | -108.30M | -113.31M |
| TaxProvision | 21.00K | 18.00K | 83.00K | 40.00K |
| PretaxIncome | -81.25M | -81.27M | -108.21M | -113.28M |
| OtherIncomeExpense | -142.00K | -18.48M | -17.71M | 61.00K |
| OtherNonOperatingIncomeExpenses | -142.00K | -18.48M | -4.07M | 61.00K |
| SpecialIncomeCharges | 0.00 | -13.64M | 0.00 | 0.00 |
| ImpairmentOfCapitalAssets | 0.00 | 5.57M | 0.00 | 0.00 |
| RestructuringAndMergernAcquisition | 0.00 | 8.08M | 0.00 | 0.00 |
| NetNonOperatingInterestIncomeExpense | 6.95M | 5.49M | 5.79M | 2.19M |
| InterestExpenseNonOperating | 205.00K | 24.00K | 110.00K | 201.00K |
| InterestIncomeNonOperating | 7.16M | 5.51M | 5.90M | 2.40M |
| OperatingIncome | -88.06M | -68.27M | -96.29M | -115.53M |
| OperatingExpense | 103.83M | 95.09M | 114.50M | 128.88M |
| ResearchAndDevelopment | 50.26M | 48.91M | 64.78M | 64.91M |
| SellingGeneralAndAdministration | 53.57M | 46.19M | 49.73M | 63.97M |
| GrossProfit | 15.78M | 26.82M | 18.21M | 13.35M |
| CostOfRevenue | 53.87M | 57.79M | 55.27M | 51.70M |
| TotalRevenue | 69.65M | 84.61M | 73.48M | 65.05M |
| OperatingRevenue | 68.33M | 84.49M | 73.08M | 64.64M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 102.48M | 85.17M | 50.48M | 46.71M |
| ShareIssued | 102.48M | 85.17M | 50.48M | 46.71M |
| TotalDebt | 39.95M | 44.25M | 47.73M | 48.65M |
| TangibleBookValue | 261.19M | 202.96M | 129.44M | 218.14M |
| InvestedCapital | 262.38M | 204.63M | 131.09M | 220.36M |
| WorkingCapital | 228.32M | 171.89M | 99.51M | 166.57M |
| NetTangibleAssets | 261.19M | 202.96M | 129.44M | 218.14M |
| CapitalLeaseObligations | 38.76M | 42.58M | 46.08M | 46.43M |
| CommonStockEquity | 261.19M | 202.96M | 129.44M | 218.14M |
| TotalCapitalization | 261.19M | 202.96M | 129.44M | 218.14M |
| TotalEquityGrossMinorityInterest | 261.19M | 202.96M | 129.44M | 218.14M |
| StockholdersEquity | 261.19M | 202.96M | 129.44M | 218.14M |
| GainsLossesNotAffectingRetainedEarnings | 104.00K | -23.00K | -222.00K | -912.00K |
| OtherEquityAdjustments | 104.00K | -23.00K | -222.00K | -912.00K |
| RetainedEarnings | -631.26M | -549.99M | -468.71M | -360.41M |
| AdditionalPaidInCapital | 892.33M | 752.96M | 598.36M | 579.46M |
| CapitalStock | 10.00K | 9.00K | 5.00K | 5.00K |
| CommonStock | 10.00K | 9.00K | 5.00K | 5.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 72.98M | 67.31M | 95.66M | 74.56M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 33.35M | 36.19M | 48.42M | 41.43M |
| OtherNonCurrentLiabilities | 1.48M | 1.30M | 5.16M | 389.00K |
| DerivativeProductLiabilities | 0.00 | 4.94M | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 31.87M | 34.88M | 38.32M | 41.04M |
| LongTermCapitalLeaseObligation | 31.87M | 34.88M | 38.32M | 41.04M |
| CurrentLiabilities | 39.63M | 31.13M | 47.23M | 33.13M |
| OtherCurrentLiabilities | 5.46M | 2.02M | 6.49M | |
| CurrentDeferredLiabilities | 1.56M | 3.10M | 3.29M | 1.29M |
| CurrentDeferredRevenue | 1.56M | 3.10M | 3.29M | 1.29M |
| CurrentDebtAndCapitalLeaseObligation | 8.08M | 9.37M | 9.41M | 7.61M |
| CurrentCapitalLeaseObligation | 6.89M | 7.70M | 7.76M | 5.39M |
| CurrentDebt | 1.19M | 1.67M | 1.65M | 2.22M |
| OtherCurrentBorrowings | 1.19M | 1.67M | 1.65M | 2.22M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 7.34M | 8.85M | 13.13M | 9.55M |
| PayablesAndAccruedExpenses | 17.19M | 7.80M | 14.92M | 14.68M |
| CurrentAccruedExpenses | 4.20M | 1.40M | 0.00 | 1.70M |
| Payables | 12.99M | 6.40M | 14.92M | 12.98M |
| TotalTaxPayable | 37.00K | 123.00K | 121.00K | |
| AccountsPayable | 12.99M | 6.40M | 14.92M | 12.85M |
| TotalAssets | 334.16M | 270.27M | 225.10M | 292.70M |
| TotalNonCurrentAssets | 66.21M | 67.25M | 78.36M | 93.00M |
| OtherNonCurrentAssets | 6.28M | 2.53M | 3.14M | 4.59M |
| NetPPE | 59.93M | 64.73M | 75.22M | 88.42M |
| AccumulatedDepreciation | -53.91M | -46.04M | -37.67M | -26.93M |
| GrossPPE | 113.84M | 110.77M | 112.89M | 115.34M |
| Leases | 41.69M | 41.56M | 40.81M | 40.37M |
| ConstructionInProgress | 56.00K | 899.00K | 3.48M | 3.99M |
| OtherProperties | 15.12M | 16.45M | 17.85M | 26.48M |
| MachineryFurnitureEquipment | 56.98M | 51.86M | 50.74M | 44.50M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 267.95M | 203.01M | 146.74M | 199.70M |
| OtherCurrentAssets | 5.65M | 3.93M | 4.36M | 6.81M |
| CurrentDeferredAssets | 887.00K | 1.96M | 4.81M | 2.21M |
| PrepaidAssets | 7.09M | |||
| Inventory | 5.26M | 3.98M | 5.66M | 6.38M |
| RawMaterials | 5.26M | 3.98M | 5.66M | 6.38M |
| Receivables | 16.20M | 8.14M | 17.73M | 16.64M |
| AccountsReceivable | 16.20M | 8.14M | 17.73M | 16.64M |
| CashCashEquivalentsAndShortTermInvestments | 239.95M | 185.01M | 114.18M | 167.66M |
| OtherShortTermInvestments | 115.71M | 93.59M | 57.20M | 78.53M |
| CashAndCashEquivalents | 124.25M | 91.42M | 56.98M | 89.13M |
| CashEquivalents | 119.33M | 90.26M | 53.34M | 83.51M |
| CashFinancial | 4.92M | 1.15M | 3.65M | 5.62M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -79.45M | -46.75M | -67.17M | -120.13M |
| RepaymentOfDebt | -2.00M | -1.13M | -3.26M | -2.29M |
| IssuanceOfDebt | 2.59M | 0.00 | 3.44M | 1.19M |
| IssuanceOfCapitalStock | 126.80M | 97.82M | 3.51M | 0.00 |
| CapitalExpenditure | -4.50M | -1.60M | -10.91M | -49.90M |
| InterestPaidSupplementalData | 0.00 | 0.00 | 0.00 | |
| IncomeTaxPaidSupplementalData | 23.00K | 38.00K | 64.00K | 47.00K |
| EndCashPosition | 126.03M | 93.20M | 58.77M | 90.92M |
| BeginningCashPosition | 93.20M | 58.77M | 90.92M | 107.38M |
| EffectOfExchangeRateChanges | 6.00K | -22.00K | -16.00K | -127.00K |
| ChangesInCash | 32.82M | 34.45M | -32.13M | -16.33M |
| FinancingCashFlow | 130.34M | 114.67M | 11.03M | 1.37M |
| CashFlowFromContinuingFinancingActivities | 130.34M | 114.67M | 11.03M | 1.37M |
| NetOtherFinancingCharges | -189.00K | -1.23M | -342.00K | |
| ProceedsFromStockOptionExercised | 3.15M | 19.21M | 7.34M | 2.46M |
| NetCommonStockIssuance | 126.80M | 97.82M | 3.51M | 0.00 |
| CommonStockIssuance | 126.80M | 97.82M | 3.51M | 0.00 |
| NetIssuancePaymentsOfDebt | 585.00K | -1.13M | 174.00K | -1.10M |
| NetLongTermDebtIssuance | 585.00K | -1.13M | 174.00K | -1.10M |
| LongTermDebtPayments | -2.00M | -1.13M | -3.26M | -2.29M |
| LongTermDebtIssuance | 2.59M | 0.00 | 3.44M | 1.19M |
| InvestingCashFlow | -22.57M | -35.07M | 13.10M | 52.54M |
| CashFlowFromContinuingInvestingActivities | -22.57M | -35.07M | 13.10M | 52.54M |
| NetInvestmentPurchaseAndSale | -18.06M | -33.71M | 24.01M | 102.43M |
| SaleOfInvestment | 192.11M | 88.00M | 127.95M | 223.92M |
| PurchaseOfInvestment | -210.17M | -121.71M | -103.94M | -121.49M |
| NetPPEPurchaseAndSale | -4.50M | -1.36M | -10.91M | -49.90M |
| SaleOfPPE | 0.00 | 242.00K | 0.00 | |
| PurchaseOfPPE | -4.50M | -1.60M | -10.91M | -49.90M |
| OperatingCashFlow | -74.95M | -45.15M | -56.26M | -70.23M |
| CashFlowFromContinuingOperatingActivities | -74.95M | -45.15M | -56.26M | -70.23M |
| ChangeInWorkingCapital | -10.19M | -2.59M | 13.48M | 10.61M |
| ChangeInOtherWorkingCapital | -1.54M | -4.12M | 5.95M | -2.72M |
| ChangeInOtherCurrentLiabilities | -5.02M | -2.31M | 884.00K | 12.39M |
| ChangeInPayablesAndAccruedExpense | 6.86M | -11.32M | 5.92M | 1.61M |
| ChangeInAccruedExpense | 2.31M | -2.40M | 742.00K | -1.48M |
| ChangeInPayable | 4.55M | -8.92M | 5.18M | 3.09M |
| ChangeInAccountPayable | 4.55M | -8.92M | 5.18M | 3.09M |
| ChangeInPrepaidAssets | -2.22M | 1.14M | 3.75M | 484.00K |
| ChangeInInventory | -204.00K | 4.42M | -1.93M | -2.98M |
| ChangeInReceivables | -8.06M | 9.59M | -1.09M | 1.82M |
| ChangesInAccountReceivables | -8.06M | 9.59M | -1.09M | 1.82M |
| OtherNonCashItems | 1.03M | 1.49M | 5.62M | 4.55M |
| StockBasedCompensation | 9.43M | 10.69M | 14.05M | 19.43M |
| AssetImpairmentCharge | 0.00 | 5.57M | 0.00 | 0.00 |
| AmortizationOfSecurities | -3.99M | -2.67M | -2.00M | 57.00K |
| DepreciationAmortizationDepletion | 10.05M | 10.94M | 11.30M | 8.43M |
| DepreciationAndAmortization | 10.05M | 10.94M | 11.30M | 8.43M |
| OperatingGainsLosses | 18.27M | 4.03M | ||
| GainLossOnInvestmentSecurities | 18.27M | 4.03M | ||
| NetIncomeFromContinuingOperations | -81.27M | -81.28M | -108.30M | -113.31M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for /PSNL
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|